Cholesterol Absorption Inhibitors

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 183 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Pharmacology of Antihyperlipidemic Medications for Laboratory Professionals. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Pharmacology of Antihyperlipidemic Medications for Laboratory Professionals (online CE course)
Cholesterol Absorption Inhibitors

Drug example: Ezetimibe
Mechanism of action: Normally, transporters exist in the GI tract to facilitate the absorption of cholesterol from digested foods. Ezetimibe inhibits a transporter involved in this process, which causes a decrease in the amount of cholesterol absorbed. This initiates a series of changes in the liver that ultimately results in decreased LDL.
Use: Ezetimibe can decrease LDL cholesterol by 15-20% alone. It is often combined with a “statin” in patients who need to obtain an even larger decrease in LDL cholesterol than a statin alone can provide.
Drug toxicity: There is little to say about the side effects or toxicity of ezetimibe, as it is well tolerated by patients. If it is used with a statin, however, there is an increased risk of liver toxicity.